Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Baris Kucukkaraduman"'
Autor:
Seyhan Turk, Can Turk, Muhammad Waqas Akbar, Baris Kucukkaraduman, Murat Isbilen, Secil Demirkol Canli, Umit Yavuz Malkan, Mufide Okay, Gulberk Ucar, Nilgun Sayinalp, Ibrahim Celalettin Haznedaroglu, Ali Osmay Gure
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242497 (2020)
Despite the availability of various treatment protocols, response to therapy in patients with Acute Myeloid Leukemia (AML) remains largely unpredictable. Transcriptomic profiling studies have thus far revealed the presence of molecular subtypes of AM
Externí odkaz:
https://doaj.org/article/f41c32244d734aecadf1c1fe9010391e
Autor:
Baris Kucukkaraduman, Ekin Gokce Cicek, Muhammad Waqas Akbar, Secil Demirkol Canli, Burcak Vural, Ali Osmay Gure
Publikováno v:
Molecules, Vol 26, Iss 19, p 5858 (2021)
Numerous natural products exhibit antiproliferative activity against cancer cells by modulating various biological pathways. In this study, we investigated the potential use of eight natural compounds (apigenin, curcumin, epigallocatechin gallate, fi
Externí odkaz:
https://doaj.org/article/67299651a0a3438b8947f9c4436fa624
Autor:
Sinem Yilmaz-Ozcan, Asli Sade, Baris Kucukkaraduman, Yasemin Kaygusuz, Kerem Mert Senses, Sreeparna Banerjee, Ali Osmay Gure
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107905 (2014)
Cancer-testis (CT) genes are expressed in various cancers but not in normal tissues other than in cells of the germline. Although DNA demethylation of promoter-proximal CpGs of CT genes is linked to their expression in cancer, the mechanisms leading
Externí odkaz:
https://doaj.org/article/48db675666544b6d81fc1a1ef5cc833d
Autor:
Gure, Secil Demirkol Canli, Meral Uner, Baris Kucukkaraduman, Diren Arda Karaoglu, Aynur Isik, Nesrin Turhan, Aytekin Akyol, Ismail Gomceli, Ali Osmay
Publikováno v:
Cancers; Volume 15; Issue 11; Pages: 3035
Background: Molecular biomarkers that predict disease progression can help identify tumor subtypes and shape treatment plans. In this study, we aimed to identify robust biomarkers of prognosis in gastric cancer based on transcriptomic data obtained f
Autor:
Baris Kucukkaraduman, Muhammad Waqas Akbar, Zeynep Ozge Ayyildiz, Can Turk, Ali O. Gure, Kerem Mert Senses, Michal Lotem, Murat Isbilen, Maurizio Botta, Anna Lucia Fallacara
Publikováno v:
ACS Medicinal Chemistry Letters
ACS Med Chem Lett
ACS Med Chem Lett
[Image: see text] Melanoma is a highly aggressive cancer with poor prognosis. Although more than 80% of melanomas harbor an activating mutation in genes within the MAPK pathway, which are mutually exclusive, usefulness of therapies targeting MAPK pat
Autor:
Nevin Belder, Murat Isbilen, Ali O. Gure, Ozgur Sahin, Baris Kucukkaraduman, Muhammad Waqas Akbar, Secil Demirkol Canli, Can Turk
Publikováno v:
Journal of Cancer
Aims: Molecular heterogeneity of breast cancer results in variation in morphology, metastatic potential and response to therapy. We previously showed that breast cancer cell line sub-groups obtained by a clustering approach using highly variable gene
Autor:
Burçak Vural, Ali O. Gure, Baris Kucukkaraduman, Muhammad Waqas Akbar, Secil Demirkol Canli, Ekin Gokce Cicek
Publikováno v:
Molecules, Vol 26, Iss 5858, p 5858 (2021)
Molecules
Volume 26
Issue 19
Molecules
Volume 26
Issue 19
Numerous natural products exhibit antiproliferative activity against cancer cells by modulating various biological pathways. In this study, we investigated the potential use of eight natural compounds (apigenin, curcumin, epigallocatechin gallate, fi
Autor:
Altay Burak Dalan, Aysegul Kuskucu, Uğur Türe, Cumhur Kaan Yaltirik, Mesut Sahin, Sukru Gulluoglu, Omer Faruk Bayrak, Muhammad Waqas Akbar, Baris Kucukkaraduman, Emre Can Tuysuz, Ali O. Gure
Publikováno v:
Brain Research
Although glioblastomas are common, there remains a need to elucidate the underlying mechanisms behind their initiation and progression and identify molecular pathways for improving treatment. In this study, sixteen fresh-frozen glioblastoma samples a
Autor:
Secil Demirkol Canli, Baris Kucukkaraduman, Hakanoglu H, Dedeoglu E, Cela I, Murat Isbilen, Akcay Ag, Azizolli S, Ali O. Gure, Muhammad Waqas Akbar
Breast cancer shows plasticity in terms of classification. Upon drug treatment and metastasis some tumors switch to another subtype leading to loss of response to therapy. In this study, we ask the question which molecular subclasses of breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61dd18cecfe86e8283b9c994de93d1f
Autor:
Secil Demirkol Canli, Ozge Sukruoglu Erdogan, Murat Isbilen, Hulya Yazici, Muhammad Waqas Akbar, Baris Kucukkaraduman, Burçak Vural, Ali O. Gure, Seda Kilic Erciyas, Ege Dedeoğlu
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 4, p e0231835 (2020)
PLoS ONE, Vol 15, Iss 4, p e0231835 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Known risk factors for this disease are currently insufficient in predicting mortality. The only FDA approved prognostic biomarker for PDAC patients is CA19-9. This, along with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c8af01a2a72cc8c842a566792c22d4
https://hdl.handle.net/11693/75674
https://hdl.handle.net/11693/75674